Moderna is “actively preparing” for the global launch of its potential coronavirus vaccine, the biotech firm said in its third-quarter earnings report. Moderna has already secured supply agreements with North America, the Middle East and other regions. "We are actively preparing for the launch of mRNA-1273 and we have signed a number of supply agreements with governments around the world," Moderna CEO Stéphane Bancel said in a press release. "Moderna is committed to the highest data quality standards and rigorous scientific research as we continue to work with regulators to advance mRNA-1273.”
Editorial use only Contact your sales representative for commercial and promotional uses.License this clip
More footage filed by NurPhoto videographers.